-
Liječenje anemije zbog nedonošenosti rekombinantnim humanim eritropoetinom : magistrski radKornhauser-Cerar, Lilijana, 1958-The anemia of prematurity (AOP) is invariably observed in very low birth weight (VLBW) infants and may become symptomatic enough to require treatment with packed red cell transfusions, that subject ... patients to numerous potentialadverse effects. Experimental and clinical data implicate inadequate erythropoietin production as an important reason that these infants acquire anemia. The recent availability of recombinant human erythropoietin (rHuEPO) has raised the possibility of stimulating erythropoiesis and thereby reduce the need for transfusions especially in the group of VLBW infants. The aim of this prospective randomized controlled trial was to assess the benefits and risks of erythropoietin omega, which has until now not been used in the treatment of AOP, versus erythrocyte transfusion. We hypothesized that using alow dose of erythropoietin omega in VLBW infants would stimulate erythropoiesis, and thus reduce postnatal hemoglobin decline and the transfusion requirements. Moreover, the cost of this treatment was compared with that of conventional therapy, consisting of erythrocyte transfusions alone. Forty-six preterm infants born at less than 31 weeks of gestation who weighed 1500 g or less at birth were randomly assigned to two groupsČ rHuEPO omega was given to infants in group A (N = 23), while group B (N = 23) served as control group and the infants did not receive this drug. Infants in group Awere receiving subcutaneously 300 IUžkgžweek of erythropoietin omega (Epomax TM) for four weeks. The treatment was started at 2 -7 weeks of postnatal age (mean 26,3 days). All patients received supplemental oral iron (3 mgžkgžday) and vitamin E therapy (5 mgžday) and were managed according to uniform transfusion guidelines. (Abstract truncated at 2000 characters).Vrsta gradiva - magistrsko delo ; neleposlovje za odrasleZaložništvo in izdelava - Zagreb : [L. Kornhauser Cerar], 2000Jezik - hrvaškiCOBISS.SI-ID - 2285076
Avtor
Kornhauser-Cerar, Lilijana, 1958-
Drugi avtorji
Gjurić, Gorjana
Teme
Infant, premature, diseases |
Anemia |
Etiology |
Anemia |
Drug therapy |
Erythropoietin, recombinant |
Pharmacology |
Nedonošenček, bolezni |
Anemija |
Etiologija |
Anemija |
Terapija z zdravili |
Rekombinantni eritropoetin |
Farmakologija |
perinatologija |
hematologija
Knjižnica | Signatura – lokacija, inventarna št. ... | Status izvoda |
---|---|---|
MF, Centralna medicinska knjižnica, Ljubljana | magistrske naloge KORNHAUSER Cerar L. Liječenje IN: 020010587 |
prosto - na dom, čas izposoje: 1 mes. |
Vnos na polico
Trajna povezava
- URL:
Faktor vpliva
Dostop do baze podatkov JCR je dovoljen samo uporabnikom iz Slovenije. Vaš trenutni IP-naslov ni na seznamu dovoljenih za dostop, zato je potrebna avtentikacija z ustreznim računom AAI.
Leto | Faktor vpliva | Izdaja | Kategorija | Razvrstitev | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Baze podatkov, v katerih je revija indeksirana
Ime baze podatkov | Področje | Leto |
---|
Povezave do osebnih bibliografij avtorjev | Povezave do podatkov o raziskovalcih v sistemu SICRIS |
---|---|
Kornhauser-Cerar, Lilijana, 1958- | 12176 |
Gjurić, Gorjana |
Izberite prevzemno mesto:
Prevzem gradiva po pošti
Obvestilo
Gesla v Splošnem geslovniku COBISS
Izbira mesta prevzema
Mesto prevzema | Status gradiva | Rezervacija |
---|
Prosimo, počakajte trenutek.